MannKind reported $919.4M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Insmed USD 35.3B 1.82B Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
MannKind USD 757M 984M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.81B 12.24B Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Xencor USD 893M 200M Mar/2026